Who are Aprexis's investors?

Aprexis's investors include CORI Innovation, FreshTracks Capital, Vermont Center for Emerging Technologies (VCET).

How much funding has Aprexis raised?

Aprexis has disclosed $721.5K raised across 1 round.

Where is Aprexis headquartered?

Aprexis is headquartered in Montpelier, US.

Aprexis

Montpelier, US · Founded 2024 · Vermont corporation · 3 known investors

Aprexis offers a platform for medication therapy management (MTM) and customizable clinical programs covering lifestyle medicine and disease management, using AI-driven patient stratification, a patient-facing mobile app, and EHR interoperability. It serves pharmacists, health plans, and Medicaid/Medicare programs, with tools addressing medication adherence, health equity, and quality metrics such as HEDIS and Stars.

Digital Health Healthtech SaaS

Founders & leadership

MICHAEL HOWEExecutive

Board

ROBERT SQUIREBoard director

Investors · 3

CORI InnovationHartland

FreshTracks CapitalShelburne · $600K – $2Mvia Lee Bouyea · led

Vermont Center for Emerging Technologies (VCET)Burlington · $25K – $250K

Reported raises · per SEC filings

Form D private placements

$721.5K disclosed across 1 round · 2023

▶$721.5KraisedOct 2024 · 9 investors · Health Insurance

Rule 506(b)

Officers, directors & promoters on the filing

MICHAEL HOWEExecutive Officer
ROBERT SQUIREDirector

Offering amount: $1.5M
Amount sold: $721.5K
Minimum investment: $10K
Proceeds to insiders: $150K
First sale: Sep 2023
Incorporated: Corporation, Vermont, 2024
Federal exemptions: 06b

Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.

Competitors · 5

by search overlap

Elion7 shared keywords

Redsail Technologies5 shared keywordsRedSail Technologies develops pharmacy management software and clinical programs for community, long-term care, outpatient, and pharma customers. Its integrated tools aim to improve patient engagement, medication adherence, and health outcomes in the pharmacy industry.

Pointclickcare5 shared keywordsPointClickCare provides a cloud-based healthcare software platform with AI-driven tools for care coordination, point-of-care documentation, medication management, and predictive analytics. It serves providers, payers, health plans, hospitals, and ACOs across the long-term and post-acute care and value-based care landscape.

ProxsysRx4 shared keywordsProxsysRx builds and operates on-site outpatient retail pharmacies for hospital systems and manages 340B drug pricing programs, PBM alignment, readmission reduction, and patient financial assistance. It serves hospitals and health systems, providing pharmacy operations, analytics, and compliance reporting at no direct cost to the hospital.

RIS Rx4 shared keywordsRIS builds a pharmacist-driven platform for pharmaceutical manufacturers to detect and prevent gross-to-net (GTN) revenue leakage, copay misuse, and fraud through real-time claim adjudication and audits. It offers copay program management and reimbursement tools aimed at protecting drug-brand revenue while keeping patients on therapy.

Companies competing with Aprexis for the same Google search keywords, organic and paid, via search-intersection analysis.

Frequently asked questions

What does Aprexis do?: Aprexis offers a platform for medication therapy management (MTM) and customizable clinical programs covering lifestyle medicine and disease management, using AI-driven patient stratification, a patient-facing mobile app, and EHR interoperability. It serves pharmacists, health plans, and Medicaid/Medicare programs, with tools addressing medication adherence, health equity, and quality metrics such as HEDIS and Stars.
Who are Aprexis's investors?: Aprexis's investors include CORI Innovation, FreshTracks Capital, Vermont Center for Emerging Technologies (VCET).
How much funding has Aprexis raised?: Aprexis has disclosed $721.5K raised across 1 round.
Where is Aprexis headquartered?: Aprexis is headquartered in Montpelier, US.